Volume 3 Issue 4

Blue toe syndrome

August 27, 2024

Introduction Blue toe syndrome (BTS) is not an uncommon referral, with vascular services often being the first port of call from primary care or the emergency department setting. It is a condition which is often overlooked, misdiagnosed or falsely labelled in the wider medical setting. Nevertheless, it warrants a thorough history, examination and assessment due…

Read More

How do vascular surgery trainees optimise simulation-based learning? A qualitative study

August 27, 2024

Introduction Vascular surgery has significantly evolved since the turn of the 20th century with a much wider repertoire of increasingly complex procedures expected of the modern surgeon, thus leading to increasing specialisation. Traditionally, vascular surgery was a sub-speciality within general surgery but it has now evolved into its own distinct speciality. In tandem, operative exposure…

Read More

Understanding variation in the management of AAA in the UK: composition and function of multidisciplinary team meetings and information resources provided to patients

August 26, 2024

Introduction There is marked national1,2 and international3 variation in abdominal aortic aneurysm (AAA) repair practice and, more specifically, in the proportion of patients undergoing open surgical repair (OSR), endovascular aneurysm repair (EVAR) or no repair (conservative management). In 2022, the UK National Vascular Registry (NVR) reported that 59% of 2,744 patients undergoing repair of infrarenal…

Read More

Safety and efficacy of tranexamic acid in major non-cardiac vascular surgery: a systematic review and meta-analysis

August 26, 2024

Introduction Tranexamic acid (TXA) is a synthetic lysine analogue that inhibits the conversion of plasminogen to plasmin, thereby inhibiting fibrinolysis.1 Large pragmatic randomised controlled trials (RCTs) have demonstrated that TXA is associated with a reduction in mortality in patients with major traumatic haemorrhage,2 postpartum haemorrhage3 and mild to moderate traumatic brain injury4; reduced transfusion requirements…

Read More

The incidence of surgical site infection following transmetatarsal amputation: a systematic review

August 18, 2024

Introduction Transmetatarsal amputations (TMAs) were first popularised in 1949 by McKittrick et al, who used this procedure as an alternative to more proximal amputations when addressing gangrene or infection.1 Its use has continued as an effective surgical approach in treating forefoot gangrene, infection and chronic ulceration, most commonly in patients with diabetic foot or vascular…

Read More